Educational Recommendations on Selected Analytical and Clinical Aspects of Natriuretic Peptides with a Focus on Heart Failure: A Report from the IFCC Committee on Clinical Applications of Cardiac Bio-Markers

Peter A Kavsak, Carolyn S P Lam, Amy K Saenger, Allan S Jaffe, Paul Collinson, Kari Pulkki, Tobjørn Omland, Guillaume Lefèvre, Richard Body, Jordi Ordonez-Llanos, Fred S Apple

Research output: Contribution to journalArticlepeer-review

Abstract

The IFCC Committee on Clinical Applications of Cardiac Bio-Markers (C-CB) has directives and initiatives focused on providing evidence-based educational resources to aid and improve understanding around key analytical and clinical aspects of cardiac biomarkers used in clinical practice and the research setting. As a task force, we have previously published position statements and recommendations focused on use and analytical aspects of high-sensitivity cardiac troponin assays. The current educational document is the first from the C-CB highlighting important biochemical, analytical, and clinical aspects as they relate to the natriuretic peptides (NPs), including B-type natriuretic peptide (BNP) and N-terminal pro-B-type natriuretic peptide (NT-proBNP), with a focus on heart failure.

Original languageEnglish
Pages (from-to)1221-1227
Number of pages7
JournalClinical Chemistry
Volume65
Issue number10
Early online date1 Oct 2019
DOIs
Publication statusPublished - 4 Jan 2020

Fingerprint

Dive into the research topics of 'Educational Recommendations on Selected Analytical and Clinical Aspects of Natriuretic Peptides with a Focus on Heart Failure: A Report from the IFCC Committee on Clinical Applications of Cardiac Bio-Markers'. Together they form a unique fingerprint.

Cite this